Inventor
ANDREWS DAVID R
US20 patents
⚠️ This page may combine multiple inventors who share the name “ANDREWS DAVID R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
16 patentsUS6958337B2Oct 25, 2005
Crystalline antifungal polymorph
SCHERING CORP20 citations92
US5625064AApr 29, 1997
Process for the preparation of triazolones
SCHERING CORP25 citations92
US5502183AMar 26, 1996
Steroid intermediates and processes for their preparation
SCHERING CORP24 citations91
US4634698AJan 6, 1987
Antiglaucoma agents
SCHERING CORP10 citations74
US5616777AApr 1, 1997
Chiral hydrazine derivatives
SCHERING CORP8 citations73
US4885293ADec 5, 1989
Antiglaucoma agents
SCHERING CORP8 citations73
US4616012AOct 7, 1986
Carboxyalkyl dipeptides as antiglaucoma agents
SCHERING CORP20 citations72
US4559340ADec 17, 1985
Antihypertensive agents
SCHERING CORP14 citations72
US4556655ADec 3, 1985
Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity
SCHERING CORP4 citations63
US5017567AMay 21, 1991
Carboxyalkyl dipeptides as antiglaucoma agents
SCHERING CORP4 citations61
US4826816AMay 2, 1989
Antihypertensive compounds
SCHERING CORP1 citations52
US4906635AMar 6, 1990
Carboxyalkyl dipeptides as antiglaucoma agents
SCHERING CORP1 citations51
US4778795AOct 18, 1988
Carboxyalkyl dipeptides as antiglaucoma agents
SCHERING CORP1 citations51
US6872826B2Mar 29, 2005
Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
SCHERING CORP0 citations47
US7745626B2Jun 29, 2010
Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
SCHERING CORP0 citations46
US7129357B2Oct 31, 2006
Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors
SCHERING CORP0 citations36